Literature DB >> 26800367

Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM).

Yan Zhang1, Susan A Gauthier2, Ajay Gupta3, Joseph Comunale3, Gloria Chia-Yi Chiang3, Dong Zhou3, Weiwei Chen1, Ashley E Giambrone4, Wenzhen Zhu1, Yi Wang3,5.   

Abstract

PURPOSE: To measure the longitudinal change in multiple sclerosis (MS) lesion susceptibility using quantitative susceptibility mapping (QSM).
MATERIALS AND METHODS: The study was approved by our Institutional Review Board. Longitudinal changes in quantitative susceptibility values of new enhanced-with-Gd MS lesions were measured at baseline magnetic resonance imaging (MRI) and on a follow-up MRI in 29 patients within 2 years using a 3D multiple echo gradient echo sequence on a 3T scanner. Paired t-test and the generalized estimating equations (GEE) model was used to analyze the longitudinal change.
RESULTS: Lesion susceptibility values relative to normal-appearing white matter (NAWM) changed from 3.61 ± 6.11 ppb when enhanced-with-Gd at the baseline MRI to 20.42 ± 10.23 ppb when not-enhanced-with-Gd at the follow-up MRI (P < 0.001).
CONCLUSION: MS lesion susceptibility value increases significantly as the lesion evolves from enhanced-with-Gd to not-enhanced-with-Gd, serving as a disease biomarker. J. Magn. Reson. Imaging 2016;44:426-432.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  gadolinium enhancement; longitudinal change; magnetic resonance imaging; multiple sclerosis; quantitative susceptibility mapping (QSM)

Mesh:

Year:  2016        PMID: 26800367      PMCID: PMC4946979          DOI: 10.1002/jmri.25144

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  26 in total

1.  Improved optimization for the robust and accurate linear registration and motion correction of brain images.

Authors:  Mark Jenkinson; Peter Bannister; Michael Brady; Stephen Smith
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

2.  Iron deposition in multiple sclerosis lesions measured by susceptibility-weighted imaging filtered phase: a case control study.

Authors:  Jesper Hagemeier; Mari Heininen-Brown; Guy U Poloni; Niels Bergsland; Christopher R Magnano; Jacqueline Durfee; Cheryl Kennedy; Ellen Carl; Bianca Weinstock-Guttman; Michael G Dwyer; Robert Zivadinov
Journal:  J Magn Reson Imaging       Date:  2012-03-07       Impact factor: 4.813

3.  Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion.

Authors:  Michael H Barnett; John W Prineas
Journal:  Ann Neurol       Date:  2004-04       Impact factor: 10.422

4.  A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis.

Authors:  Wei Bian; Kristin Harter; Kathryn E Hammond-Rosenbluth; Janine M Lupo; Duan Xu; Douglas Ac Kelley; Daniel B Vigneron; Sarah J Nelson; Daniel Pelletier
Journal:  Mult Scler       Date:  2012-05-28       Impact factor: 6.312

5.  Magnetic susceptibility contrast variations in multiple sclerosis lesions.

Authors:  Xu Li; Daniel M Harrison; Hongjun Liu; Craig K Jones; Jiwon Oh; Peter A Calabresi; Peter C M van Zijl
Journal:  J Magn Reson Imaging       Date:  2015-06-14       Impact factor: 4.813

6.  Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis.

Authors:  Dmitriy A Yablonskiy; Jie Luo; Alexander L Sukstanskii; Aditi Iyer; Anne H Cross
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

7.  Seven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process.

Authors:  Martina Absinta; Pascal Sati; María I Gaitán; Pietro Maggi; Irene C M Cortese; Massimo Filippi; Daniel S Reich
Journal:  Ann Neurol       Date:  2013-09-16       Impact factor: 10.422

8.  Magnetic resonance frequency shifts during acute MS lesion formation.

Authors:  Vanessa Wiggermann; Enedino Hernández Torres; Irene M Vavasour; G R Wayne Moore; Cornelia Laule; Alex L MacKay; David K B Li; Anthony Traboulsee; Alexander Rauscher
Journal:  Neurology       Date:  2013-06-12       Impact factor: 9.910

9.  Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: application to determine iron content in deep gray matter structures.

Authors:  Issel Anne L Lim; Andreia V Faria; Xu Li; Johnny T C Hsu; Raag D Airan; Susumu Mori; Peter C M van Zijl
Journal:  Neuroimage       Date:  2013-06-12       Impact factor: 6.556

10.  Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions.

Authors:  Veela Mehta; Wei Pei; Grant Yang; Suyang Li; Eashwar Swamy; Aaron Boster; Petra Schmalbrock; David Pitt
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more
  29 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

2.  Heterogeneity of Cortical Lesion Susceptibility Mapping in Multiple Sclerosis.

Authors:  M Castellaro; R Magliozzi; A Palombit; M Pitteri; E Silvestri; V Camera; S Montemezzi; F B Pizzini; A Bertoldo; R Reynolds; S Monaco; M Calabrese
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

3.  Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.

Authors:  Ulrike W Kaunzner; Yeona Kang; Shun Zhang; Eric Morris; Yihao Yao; Sneha Pandya; Sandra M Hurtado Rua; Calvin Park; Kelly M Gillen; Thanh D Nguyen; Yi Wang; David Pitt; Susan A Gauthier
Journal:  Brain       Date:  2019-01-01       Impact factor: 13.501

4.  Automated adaptive preconditioner for quantitative susceptibility mapping.

Authors:  Zhe Liu; Yan Wen; Pascal Spincemaille; Shun Zhang; Yihao Yao; Thanh D Nguyen; Yi Wang
Journal:  Magn Reson Med       Date:  2019-08-11       Impact factor: 4.668

Review 5.  MRI in the assessment and monitoring of multiple sclerosis: an update on best practice.

Authors:  Ulrike W Kaunzner; Susan A Gauthier
Journal:  Ther Adv Neurol Disord       Date:  2017-05-12       Impact factor: 6.570

6.  Magnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM.

Authors:  Kofi Deh; Gerald D Ponath; Zaki Molvi; Gian-Carlo T Parel; Kelly M Gillen; Shun Zhang; Thanh D Nguyen; Pascal Spincemaille; Yinghua Ma; Ajay Gupta; Susan A Gauthier; David Pitt; Yi Wang
Journal:  J Magn Reson Imaging       Date:  2018-03-08       Impact factor: 4.813

7.  Longitudinal ultra-high field MRI of brain lesions in neuromyelitis optica spectrum disorders.

Authors:  Sanjeev Chawla; Yulin Ge; Jens Wuerfel; Shadi Asadollahi; Suyash Mohan; Friedemann Paul; Tim Sinnecker; Ilya Kister
Journal:  Mult Scler Relat Disord       Date:  2020-03-25       Impact factor: 4.339

Review 8.  The Use of Noncontrast Quantitative MRI to Detect Gadolinium-Enhancing Multiple Sclerosis Brain Lesions: A Systematic Review and Meta-Analysis.

Authors:  A Gupta; K Al-Dasuqi; F Xia; G Askin; Y Zhao; D Delgado; Y Wang
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-18       Impact factor: 3.825

9.  Clinical Integration of Automated Processing for Brain Quantitative Susceptibility Mapping: Multi-Site Reproducibility and Single-Site Robustness.

Authors:  Pascal Spincemaille; Zhe Liu; Shun Zhang; Ilhami Kovanlikaya; Matteo Ippoliti; Marcus Makowski; Richard Watts; Ludovic de Rochefort; Vijay Venkatraman; Patricia Desmond; Mathieu D Santin; Stéphane Lehéricy; Brian H Kopell; Patrice Péran; Yi Wang
Journal:  J Neuroimaging       Date:  2019-08-04       Impact factor: 2.486

10.  Magnetic Susceptibility from Quantitative Susceptibility Mapping Can Differentiate New Enhancing from Nonenhancing Multiple Sclerosis Lesions without Gadolinium Injection.

Authors:  Y Zhang; S A Gauthier; A Gupta; L Tu; J Comunale; G C-Y Chiang; W Chen; C A Salustri; W Zhu; Y Wang
Journal:  AJNR Am J Neuroradiol       Date:  2016-06-30       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.